Which obesity index is the most useful marker for predicting hepatic steatosis in children and adolescents with obesity? A cross-sectional study using quantitative magnetic resonance imaging.
暂无分享,去创建一个
YoonMyung Kim | Sarah Woo | K. Park | Hyunjung Lim | Y. Park | Jun-hee Han | Hae-Jin Ko | Min-Jeong Kim
[1] N. Méndez-Sánchez,et al. Detangling the interrelations between MAFLD, insulin resistance, and key hormones , 2022, Hormones.
[2] Zhihui Li,et al. Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Children and Adolescents: Systematic Review and Meta-Analysis , 2021, International Journal of Public Health.
[3] Neena E Thomas-Eapen. Childhood Obesity. , 2021, Primary care.
[4] B. Liao,et al. Steatosis grading consistency between controlled attenuation parameter and MRI-PDFF in monitoring metabolic associated fatty liver disease , 2021, Therapeutic advances in chronic disease.
[5] J. Schwimmer,et al. Epidemiology of Pediatric Nonalcoholic Fatty Liver Disease , 2021, Clinical liver disease.
[6] Anam Bashir,et al. Childhood Obesity as a Predictor of Coronary Artery Disease in Adults: A Literature Review , 2020, Cureus.
[7] E. D. del Giudice,et al. Pediatric obesity-related non-alcoholic fatty liver disease: waist-to-height ratio best anthropometrical predictor , 2020, Pediatric Research.
[8] Geir Bjorklund,et al. Obesity and Insulin Resistance: Associations with Chronic Inflammation, Genetic and Epigenetic Factors. , 2020, Current medicinal chemistry.
[9] C. Mantzoros,et al. Adiponectin and leptin in the diagnosis and therapy of NAFLD. , 2019, Metabolism: clinical and experimental.
[10] C. Mantzoros,et al. Leptin trajectories from birth to mid-childhood and cardio-metabolic health in early adolescence. , 2019, Metabolism: clinical and experimental.
[11] Hong Chen,et al. Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From “two hit theory” to “multiple hit model” , 2018, World journal of gastroenterology.
[12] Kyungwon Oh,et al. The 2017 Korean National Growth Charts for children and adolescents: development, improvement, and prospects , 2018, Korean journal of pediatrics.
[13] C. Byrne,et al. Nonalcoholic Fatty Liver Disease in Children , 2018, Seminars in Liver Disease.
[14] Rong Yu,et al. A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease , 2017, Lipids in Health and Disease.
[15] Z. Younossi,et al. Pediatric Non-Alcoholic Fatty Liver Disease , 2017, Children.
[16] M Hassan Murad,et al. Pediatric Obesity-Assessment, Treatment, and Prevention: An Endocrine Society Clinical Practice Guideline. , 2017, The Journal of clinical endocrinology and metabolism.
[17] Wenjian Song,et al. Diagnostic Value of CK-18, FGF-21, and Related Biomarker Panel in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis , 2017, BioMed research international.
[18] E. Tsochatzis,et al. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). , 2016, Metabolism: clinical and experimental.
[19] E. Yu,et al. Intimate association of visceral obesity with non‐alcoholic fatty liver disease in healthy Asians: A case‐control study , 2015, Journal of gastroenterology and hepatology.
[20] C. Sirlin,et al. Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease , 2015, Hepatology.
[21] A. Gamst,et al. Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. , 2015, Radiology.
[22] M. Hofker,et al. Nonalcoholic fatty liver disease: A main driver of insulin resistance or a dangerous liaison? , 2014, Biochimica et biophysica acta.
[23] A. Feldstein,et al. Serum Cytokeratin-18 Fragment Levels Are Useful Biomarkers for Nonalcoholic Steatohepatitis in Children , 2013, The American Journal of Gastroenterology.
[24] S. Caprio,et al. The Association Between Hepatic Fat Content and Liver Injury in Obese Children and Adolescents , 2013, Diabetes Care.
[25] J. Stoker,et al. Accuracy of prediction scores and novel biomarkers for predicting nonalcoholic fatty liver disease in obese children , 2013, Obesity.
[26] J. Lavine,et al. Advances in pediatric nonalcoholic fatty liver disease. , 2011, Pediatric clinics of North America.
[27] J. Mandrekar. Receiver operating characteristic curve in diagnostic test assessment. , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[28] Rocio Lopez,et al. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis , 2010, Hepatology.
[29] J. Schwimmer,et al. Symptoms and quality of life in obese children and adolescents with non‐alcoholic fatty liver disease , 2010, Alimentary pharmacology & therapeutics.
[30] F. Schick,et al. Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. , 2009, Journal of hepatology.
[31] J. Benson,et al. The natural history of non-alcoholic fatty liver disease , 2006 .
[32] J. Schwimmer,et al. Cardiovascular Risk Factors and the Metabolic Syndrome in Pediatric Nonalcoholic Fatty Liver Disease , 2008, Circulation.
[33] A. Feldstein,et al. Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis , 2008, The American Journal of Gastroenterology.
[34] Y. Murawaki,et al. The impact of visceral fat in nonalcoholic fatty liver disease: cross-sectional and longitudinal studies , 2007, Journal of Gastroenterology.
[35] Young-Chae Chang,et al. Relationship between serum adiponectin and leptin concentrations and body fat distribution. , 2004, Diabetes research and clinical practice.